ID
12422
Beschrijving
Evaluation of the Long-term Hepatitis A and B Antibody Persistence in Healthy Adult Subjects, Primed 16 to 20 Years Earlier With GSK Biologicals' Combined Hepatitis A and B Vaccine, Twinrix® (SB208127) in Study HAB-084 (208127/084); ODM derived from: https://clinicaltrials.gov/show/NCT02135666
Link
https://clinicaltrials.gov/show/NCT02135666
Trefwoorden
Versies (2)
- 17-11-15 17-11-15 -
- 17-09-21 17-09-21 -
Geüploaded op
17 november 2015
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Hepatitis B NCT02135666
Eligibility Hepatitis B NCT02135666
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
Immunosuppressive Agents
Datatype
boolean
Alias
- UMLS CUI [1]
- C0021081
- UMLS CUI [2]
- C0279021
Beschrijving
Immune-modulator therapy
Datatype
boolean
Alias
- UMLS CUI [1]
- C0279021
Beschrijving
Study Subject Participation Status
Datatype
boolean
Alias
- UMLS CUI [1]
- C2348568
Beschrijving
Administration of any hepatitis a and/or b vaccine
Datatype
boolean
Alias
- UMLS CUI [1]
- C1170008
Beschrijving
History of hepatitis a or b
Datatype
boolean
Alias
- UMLS CUI [1]
- C1875244
Beschrijving
Suspected immunosuppressive or immunologic deficiency syndromes
Datatype
boolean
Alias
- UMLS CUI [1]
- C0021079
- UMLS CUI [2]
- C0021051
Beschrijving
Immunoglobulins
Datatype
boolean
Alias
- UMLS CUI [1]
- C0021027
Similar models
Eligibility Hepatitis B NCT02135666
- StudyEvent: Eligibility
C0279021 (UMLS CUI [2])
C0021051 (UMLS CUI [2])